LIV-1 (Ladiratuzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607892

This anti-LIV-1 (Ladiratuzumab Biosimilar) antibody is a Humanized Monoclonal antibody detecting LIV-1 (Ladiratuzumab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for LIV-1 (Ladiratuzumab Biosimilar) antibody (Biotin) (ABIN7607892)

Target: LIV-1 (Ladiratuzumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This LIV-1 (Ladiratuzumab Biosimilar) antibody is conjugated to Biotin

Application: ELISA

Product Details anti-LIV-1 (Ladiratuzumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-LIV-1(ladiratuzumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for LIV-1 (Ladiratuzumab Biosimilar)

Target: LIV-1 (Ladiratuzumab Biosimilar)

Alternative Name: ladiratuzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:LIV1,SLC39A6,ZIP-6
Synonyms Antibody:hLIV22